Closed Period

RNS Number : 7826B
JPMorgan China Growth & Income PLC
04 October 2022
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

 

JPMORGAN CHINA GROWTH & INCOME PLC

(the 'Company')

 

Compliance with Market Abuse Regulation

 

 

Legal Entity Identifier: 549300S8M91P5FYONY25

Information disclosed in accordance with Market Abuse Regulation Article 19,

paragraph 11

 

 

The Company announces that it is satisfied that all inside information which the Directors and the Company may have in the period leading up to the announcement of its annual financial results for the year ended 30th September 2022 has previously been, and will continue to be, notified to the London Stock Exchange ('LSE') via a regulatory information service. Therefore, the Company is not prohibited from dealing in its own securities.

 

 

The mandatory closed period under MAR will commence on 24th October 2022 and will last until the annual financial results in respect of the year ended 30th September 2022 are published, which is expected on or around 9th December 2022.  

 

 

If in the period leading up to the announcement of the annual financial results the Directors of the Company come into the possession of any inside information, this will be notified to the London Stock Exchange without delay and before any such transactions are undertaken.

 

 

 

 

 

JPMorgan Funds Limited - Secretary

4th October 2022

 

 

For further information, please contact:

 

Lucy Dina

JPMorgan Funds Limited 

020 7742 4000

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CMCBKQBPABDDCKK
UK 100

Latest directors dealings